Étanercept = EtanerceptDESCAMPS, V.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 845-847, issn 0151-9638, 3 p.Article

AdalimumabAUBIN, F; BARTHELEMY, H.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 842-844, issn 0151-9638, 3 p.Article

Update on Alefacept SafetyWEXLER, Denise; SEARLES, Gordon; LANDELLS, Ian et al.Journal of cutaneous medicine and surgery. 2009, Vol 13, issn 1203-4754, S139-S147, SUP3Article

Nicolau Syndrome Following Etanercept AdministrationGUARNERI, Claudio; POLIMENI, Giovanni.American journal of clinical dermatology. 2010, Vol 11, pp 51-52, issn 1175-0561, 2 p., SUPP1Article

Challenges and solutions in selecting systemic antipsoriatic agentsTAN, Jerry K. L.Journal of cutaneous medicine and surgery. 2007, Vol 11, issn 1203-4754, S48-S53, SUP1Article

Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patientsJAMNITSKI, A; KRIECKAERT, C. L; NURMOHAMED, M. T et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 1, pp 88-91, issn 0003-4967, 4 p.Article

Cumulative Irritation Potential and Contact Sensitization Potential of Tazarotene Foam 0.1% in 2 Phase 1 Patch StudiesBERG, Jeffrey E; BOWMAN, James P; ALIO SAENZ, Alessandra B et al.Cutis (New York, NY). 2012, Vol 90, Num 4, pp 206-211, issn 0011-4162, 6 p.Article

Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tarARBISER, Jack L; GOVINDARAJAN, Baskaran; KLEIN, Eva et al.Journal of investigative dermatology. 2006, Vol 126, Num 6, pp 1396-1402, issn 0022-202X, 7 p.Article

Dimethylfumarate Inhibits Angiogenesis In vitro and In vivo: A Possible Role for Its Antipsoriatic Effect?GARCIA-CABALLERO, Melissa; MARI-BEFFA, Manuel; MEDINA, Miguel A et al.Journal of investigative dermatology. 2011, Vol 131, Num 6, pp 1347-1355, issn 0022-202X, 9 p.Article

Systemic antipsoriatic therapy may reverse endothelial dysfunctionBOEHNCKE, W.-H; BOEHNCKE, S.British journal of dermatology (1951). 2011, Vol 164, Num 6, pp 1397-1398, issn 0007-0963, 2 p.Article

Interstitial Granulomatous Drug Reaction to AdalimumabMARTORELL-CALATAYUD, Antonio; BALMER, Nicole; CARDENAS CARDONA, Luis Fernando et al.The American journal of dermatopathology. 2010, Vol 32, Num 4, pp 408-409, issn 0193-1091, 2 p.Article

InfliximabGOUJON, C; BACHELEZ, H.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 839-841, issn 0151-9638, 3 p.Article

Efficacy Outcomes in Patients Using Alefacept in the AWARE StudyLANDELLS, Ian; SEARLES, Gordon; BISSONNETTE, Robert et al.Journal of cutaneous medicine and surgery. 2009, Vol 13, issn 1203-4754, S122-S130, SUP3Article

The Next Phase of Real-World Clinical Experience with Alefacept: the AWARE-2 RegistrySEARLES, Gordon; BISSONNETTE, Robert; LANDELLS, Ian et al.Journal of cutaneous medicine and surgery. 2009, Vol 13, issn 1203-4754, S148-S152, SUP3Article

Gestion des traitements lourds. Adalimumab : Humira^® = Onerous treatments. Adalimumab : Humira^®LEVANG, J; AUBIN, F.Annales de dermatologie et de vénéréologie. 2008, Vol 135, Num 10, pp 710-713, issn 0151-9638, 4 p.Article

Systemic antipsoriatic therapy may reverse endothelial dysfunction: reply from authorsMARTYN-SIMMONS, C. L; SMITH, C. H; BARKER, J. N. W. N et al.British journal of dermatology (1951). 2011, Vol 164, Num 6, issn 0007-0963, p. 1398Article

T-cell clone associated with efalizumab therapyLYNCH, M; MURPHY, K; SLABY, J et al.Clinical and experimental dermatology (Print). 2011, Vol 36, Num 1, pp 99-100, issn 0307-6938, 2 p.Article

Lettre d'information pour le traitement du psoriasis par l'adalimumab (Humira^®) = Information letter on treatment of psoriasis with adalimumab (Humira^®)Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 868-870, issn 0151-9638, 3 p.Article

Frequency and Effectiveness of Dose Increase of Adalimumab, Etanercept, and Infliximab in Daily Clinical PracticeBLOM, M; KIEVIT, W; KUPER, H. H et al.Arthritis care and research. 2010, Vol 62, Num 9, pp 1335-1341, issn 0893-7524, 7 p.Article

Adalimumab : In Plaque PsoriasisCROOM, Katherine F; MCCORMACK, Paul L.American journal of clinical dermatology. 2009, Vol 10, Num 1, pp 43-50, issn 1175-0561, 8 p.Article

Alefacept revisited : Our 3-year clinical experience in 200 patients with chronic plaque psoriasisPERLMUTTER, Amy; CATHER, Jennifer; FRANKS, Billy et al.Journal of the American Academy of Dermatology. 2008, Vol 58, Num 1, pp 116-124, issn 0190-9622, 9 p.Article

Paraqueratosis granular = Granular parakeratosisGONZALEZ DE ARRIBA, M; VALLES-BLANCO, L; POLO-RODRIGUEZ, I et al.Actas dermo-sifiliográficas (Ed. impresa). 2007, Vol 98, Num 5, pp 355-357, issn 0001-7310, 3 p.Article

Conseils aux patients ayant un psoriasis et utilisant le Soriatane : Psoriasis = Recommandations in psoriasis treated by SoriataneLa Revue du praticien (Paris). 2004, Vol 54, Num 1, issn 0035-2640, p. 70Article

The efficacy of alefacept in the treatment of chronic plaque psoriasisGORDON, Kenneth B; VALENTINE, Jayme.Journal of cutaneous medicine and surgery. 2004, Vol 8, pp 3-9, issn 1203-4754, 7 p., SUP2Article

Alefacept is well tolerated in patients with chronic plaque psoriasisGOTTLIEB, Alice B.Journal of cutaneous medicine and surgery. 2004, Vol 8, pp 14-19, issn 1203-4754, 6 p., SUP2Article